Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis

By F. Salerno, A. Gerbes, P. Ginés, F. Wong, V. Arroyo. Postgraduate medical journal, 2007

1,039 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. (2018, background): “In case of no obvious cause and AKI stage >1A, 20% albumin solution at the dose of 1 g of albumin/Kg of body weight (with a maximum of 100 g of albumin) for two consecutive days should be given [307].”
KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. (2013, background): “Along the same lines, the most recent diagnostic criteria for hepatorenal syndrome include a lack of improvement in renal function after volume expansion with albumin (1 g/kg/d up to 100 g/d) for at least 2 days and withdrawal of diuretic therapy.(41) Data”
Hepatorenal syndrome: the 8th international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group (2012, background): “Rationale: In 1996, the International Ascites Club (IAC) proposed a definition and diagnostic criteria for HRS [39] which was later revised in 2007 (Table 3) [40].”